MarketFriction

Camlin Fine Sciences Ltd

NSE CAMLINFINE · BSE 532834 · Specialty Chemicals
₹91.01 -2.30%
NSE close2026-10-01
52 week range92.75 - 211.95
Market cap₹1,788 Cr.
Price band 20% Delivery 45.7%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Consolidated, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales406386377381417431432408460441425520
Expenses381363345352366375370387427420404511
Operating Profit25233129525662203321219
OPM %6%6%8%8%12%13%14%5.0%7%4.7%5.0%1.8%
Other Income22-96-15-151-8-22-0-4-24103-10
Interest201416232634151519172314
Depreciation192113151714171619162119
Profit before tax-12-10-94-23-142-08-11-9-3780-34
Tax %72%47%-13%48%-18%2,164%98%-0%65%-0%-8%-1%
Net Profit-21-14-82-35-116-70-11-15-3786-34
EPS in Rs-1.03-0.63-4.11-1.81-5.33-0.22-0.04-0.53-0.76-1.894.59-1.65
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales4895347218921,0491,1871,4121,6821,4541,6291,7231,845
Expenses3975027058199141,0001,2541,4711,2841,4021,6051,761
Operating Profit9232167313518715821117022711884
OPM %19%6%2.2%8%13%16%11%13%12%14%7%4.6%
Other Income-11412143533-4-142-2185964
Interest2431324148424164701078373
Depreciation172227293344566356617175
Profit before tax50-6-3117581059480-99-15923-0
Tax %28%-26%-22%82%49%38%36%50%6%-0%-2%
Net Profit36-4-24330656040-105-158241
EPS in Rs3.30-0.96-2.180.042.233.563.452.96-4.94-7.401.440.29
Dividend Payout %12%0%0%0%0%0%0%0%0%0%0%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth13%8%1%9%
Compounded Profit Growth-1%-6%-14%-139%
Stock Price CAGR1%-12%-17%-53%
Return on Equity-1%-2%-7%4%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital101010121212131616171919
Reserves1251672023593593916317328048488831,022
Borrowings160180331373461539550646801683652720
Other Liabilities131123126273255290282396425424467559
Total Liabilities4264796691,0161,0871,2321,4751,7902,0451,9722,0202,320
Fixed Assets106140201278272306584601858816704887
CWIP325814591792421543461033
Investments111911511777886130
Other Assets3163134426097457408619661,1361,1021,2461,370
Total Assets4264796691,0161,0871,2321,4751,7902,0451,9722,0202,320
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity4672-9-15-986117145511392382
Cash from Investing Activity-26-66-70-149-2-90-133-249-125-66-75-53
Cash from Financing Activity-15-7911822633913660-8676-25
Net Cash Flow4-1131815-12332-14-13244
Free Cash Flow195-39-34-78-4834-68-9379-1920
CFO/OP68%91%5%-33%10%77%82%111%34%110%27%90%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days7456991048688837766727479
Inventory Days184311277207219204200178255256234199
Days Payable14417111015412711999112129154180200
Cash Conversion Cycle11419626615717817318414319217412778
Working Capital Days121-6194322554042513323
ROCE %28%24%5%0%7%11%13%10%10%8%12%5%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters48.03%48.03%48.04%48.03%48.03%48.03%49.09%49.09%49.08%48.03%48.03%48.03%
FIIs1.61%0.99%1.69%1.01%0.81%0.76%1.47%2.88%2.11%2.12%0.94%0.91%
DIIs3.89%3.75%4.55%4.88%4.23%3.38%3.83%4.14%5.48%7.77%7.70%5.42%
Public46.46%47.22%45.73%46.07%46.93%47.83%45.61%43.88%43.33%42.07%43.31%45.63%
No. of Shareholders57,09862,09858,16562,68767,75061,89358,11159,53857,66152,35752,23255,178

Fundamentals

Market Cap₹ 1,788 Cr.
Current Price₹ 93.2
Book Value₹ 54.2
ROCE4.78 %
ROE3.75 %
Dividend Yield0.00 %
Face Value₹ 1.00
Compounded Sales Growth (TTM)9%
Compounded Profit Growth (TTM)-139%
Consolidated figures.
Valuation
Market capRs 1,748 Cr
Enterprise valueRs 2,315 Cr
P/E (TTM)297.32x
Price to book1.68x
Price to sales0.95x
EV / EBITDA15.64x
EV / EBIT31.77x
EV / sales1.25x
Price to cash flow21.30x
Earnings yield0.34%
P/E, 3-year average67.39x
P/B, 3-year average2.32x
P/E, 5-year average46.73x
P/B, 5-year average2.44x
Profitability
Operating margin (excl. other income)6.85%
Operating margin (incl. other income)10.27%
EBITDA margin8.02%
Pre-tax margin-0.02%
Net profit margin0.32%
Net margin, latest quarter-6.10%
ROE2.84%
ROCE6.39%
ROA1.27%
ROE, 3-year average-7.97%
ROCE, 3-year average0.40%
ROA, 3-year average-3.44%
ROE, 5-year average-1.71%
ROCE, 5-year average4.24%
ROA, 5-year average-0.78%
ROIC (approx.)4.62%
Tax rate-1.99%
Other income / net worth5.65%
Growth
Sales growth (latest year)5.81%
Sales CAGR, 3 years0.82%
Sales CAGR, 5 years7.74%
Profit CAGR, 3 years-19.06%
Profit CAGR, 5 years-11.52%
Sales growth QoQ22.38%
Profit growth QoQ-135.95%
Sales growth YoY (latest quarter)27.51%
Per share
EPS (TTM)Rs 0.31
EPS (latest year)Rs 1.44
EPS (latest quarter)Rs -1.65
EPS, 3-year averageRs -3.83
EPS, 5-year averageRs -0.86
Book value per shareRs 54.19
Sales per shareRs 96.05
Cash flow per shareRs 4.27
Free cash flow per shareRs 1.04
Efficiency
Asset turnover0.74x
Fixed asset turnover1.94x
Inventory turnover2.39x
Inventory days152 days
Debtor days79 days
Debtors turnover4.62x
Creditor days200 days
Cash conversion cycle78 days
Working capital days23 days
Leverage
Total debtRs 720 Cr
Cash and bankRs 153 Cr
Net debtRs 567 Cr
Debt to equity0.69x
Net debt / EBITDA3.83x
Interest coverage1.00x
Current ratio (filing 2026-03-31)1.27x
Quick ratio (filing 2026-03-31)0.75x
Trade payables (filing 2026-03-31)Rs 505 Cr
Owners' fund to total sources44.87%
Debt to assets31.04%
Cash flow
Cash from Operating Activity (latest year)Rs 82 Cr
Cash from Investing Activity (latest year)Rs -53 Cr
Cash from Financing Activity (latest year)Rs -25 Cr
Net Cash Flow (latest year)Rs 4 Cr
Free cash flow (latest year)Rs 20 Cr
FCFE (approx.: FCF + change in debt)Rs 88 Cr
Sales to cash flow21.00x
Statement figures
Net sales (TTM)Rs 1,845 Cr
Net sales (latest year)Rs 1,723 Cr
Sales (latest quarter)Rs 520 Cr
Operating profit excl. other income (latest year)Rs 118 Cr
Operating profit (latest quarter)Rs 9 Cr
Other income (TTM)Rs 64 Cr
EBITDA (TTM)Rs 148 Cr
PBDT (TTM)Rs 75 Cr
Profit before tax (TTM)Rs -0 Cr
Tax (latest year)Rs -0 Cr
Net profit (TTM)Rs 6 Cr
Net profit (latest year)Rs 28 Cr
Net profit (latest quarter)Rs -32 Cr
Depreciation (TTM)Rs 75 Cr
Depreciation (latest quarter)Rs 19 Cr
Interest (TTM)Rs 73 Cr
Cost of goods sold (latest year)Rs 1,206 Cr
Total expenditure (latest year)Rs 1,605 Cr
Total income (latest year)Rs 1,782 Cr
Share capitalRs 19 Cr
ReservesRs 1,022 Cr
Shareholders' fundsRs 1,041 Cr
Total assetsRs 2,320 Cr
Net blockRs 887 Cr
Capital work in progressRs 33 Cr
InvestmentsRs 30 Cr
ReceivablesRs 373 Cr
InventoryRs 504 Cr
Other liabilitiesRs 559 Cr
Shares outstanding (crore)19.21
Ownership
Promoter holding48.03% (-1.06 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 297.3 is at the 94th percentile of its own 4.5-year range (median 53.4, low 32.9, high 335.3).
P/B 1.68 is the lowest in 9.4 years (median 3.61).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
PeriodCAMLINFINENifty 50Difference
1 week-6.4%-2.8% -3.6 pts
1 month-10.9%-6.8% -4.1 pts
3 months-33.5%-7.6% -25.8 pts
6 months-6.1%+0.4% -6.5 pts
1 year-58.5%-9.9% -48.6 pts
2 years-13.9%-13.6% -0.3 pts
3 years-44.5%+14.2% -58.7 pts
5 years-52.1%+27.9% -80.0 pts
7 mutual fund schemes hold about ₹132 Cr. Over three months 5 bought more and 1 sold (share counts, price move removed).
FundWeightEst. Cr3m shares
ICICI Pru Commodities Fund1.46%63 +9%
ICICI Pru Multi Cap Fund0.18%35 +15%
ICICI Pru Multi Cap Fund0.18%33 +15%
ICICI Pru Mid Cap Fund0.01%1 +7%
ICICI Pru Mid Cap Fund0.01%1 +7%
JM Small Cap Fund0.00%0 -100%
Motilal Oswal BSE 1000 Index Fund0.00%0

Red flags

F-score 5 of 8
explainLow interest cover Interest cover 1.3x in 2026
lookProfit leans on other income Other income was 255% of pre-tax profit in 2026
lookRegulator order or action Regulator order or action 2026-04-10: Camlin Fine Sciences Limited has informed the Exchange about Action(s) taken or orders passed
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹520 Cr +27.5% vs Jun 2025. Net loss ₹34 Cr.
Against our estimate for Jun 2026: sales +27.0%, profit -178.8% in line. Our estimate for Sep 2026: sales Rs 519 Cr, profit Rs -25 Cr (how).

Activity

Compare
CompanyMcap (Cr)P/EROCE
Pidilite Industries Ltd148,80956.231.0 %
Gujarat Fluorochemicals Ltd48,40278.49.64 %
Navin Fluorine International Ltd42,25553.121.0 %
Aether Industries Ltd23,22696.811.9 %
Deepak Nitrite Ltd20,85426.311.4 %
Atul Ltd17,61422.114.9 %
Aarti Industries Ltd17,04532.66.86 %
Fine Organic Industries Ltd15,75936.021.5 %
BASF India Ltd14,87124.014.5 %
Privi Speciality Chemicals Ltd14,08440.322.3 %
Anupam Rasayan India Ltd13,40976.87.38 %
Vinati Organics Ltd12,17324.421.4 %
Elantas Beck India Ltd10,82060.921.2 %
Jubilant Ingrevia Ltd10,18032.011.4 %
Alkyl Amines Chemicals Ltd9,11140.516.6 %
No bulk or block deals on record.
Ex-dateActionFactor
2025-01-08Rights 5:41 @ Premium Rs 109/-
2024-07-24Annual General Meeting
2023-07-24Annual General Meeting
2022-07-21Annual General Meeting
2021-07-12 Annual General Meeting
2020-07-31 Annual General Meeting
2019-07-25 Annual General Meeting
2018-08-03 Annual General Meeting
2017-07-13 Annual General Meeting
2016-07-28 Annual General Meeting/ Dividend - Re 0.45/- Per Share
2015-07-27Annual General Meeting/Dividend - Re 0.45/- Per Share
DateTypeWhat it says
2026-09-15Shareholder meetingNotice of Postal Ballot
2026-09-09AppointmentAppointment of Mr Atul Pradhan as an Additional Non- Executive Independent Director of the company w.e.f. September 11, 2026.
2026-08-17Concall / analyst meetTranscript
2026-08-11Concall / analyst meetLink of Recording
2026-08-11Investor PresentationInvestor Presentation
2026-08-11Board meeting outcomeCamlin Fine Sciences Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
2026-08-11Shareholder meetingProceedings of Annual General Meeting held on August 11, 2026. Further, the company has submitted the Exchange a copy of Srutinizers report along with...
2026-08-04Concall / analyst meetSchedule of meet
2026-07-18General UpdatesLetters sent to Shareholders.
2026-07-18Shareholder meetingNotice of Annual General Meeting to be held on August 11, 2026
2026-07-09General UpdatesPress Release issued by the Company.
2026-07-07ResignationResignation of Director/KMP/SMP
2026-07-07ResignationResignation of Mr Anvarhusen Bilakhiya as Senior Management Personnel of the company w.e.f. July 07, 2026.
2026-07-07Disclosure under SEBI TakeovAshish S. Dandekar has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantia...
2026-07-01Concall / analyst meetUpdate on Analyst / Institutional Investor Meeting
2026-06-28Concall / analyst meetSchedule of meet
2026-06-18General UpdatesPress Release issued by the Company.
2026-05-29Concall / analyst meetTranscript
2026-05-26Concall / analyst meetLink of Recording
2026-05-26Change in ManagementChange in Management
2026-05-26Investor PresentationInvestor Presentation
2026-05-26Board meeting outcomeCamlin Fine Sciences Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
2026-05-24Closure of operationsClosure of operations
2026-05-24Disruption of OperationsDisruption of Operations
2026-05-20Concall / analyst meetSchedule of meet
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Scrip PE is greater than 50 (4 trailing quarters)

Quick answers

What is the market cap of Camlin Fine Sciences Ltd?

Camlin Fine Sciences Ltd (CAMLINFINE) has a market capitalisation of Rs 1,788 Cr. at the 2026-10-01 close.

What were Camlin Fine Sciences Ltd's latest quarterly results?

In the Jun 2026 quarter, Camlin Fine Sciences Ltd sales was Rs 520 Cr (+27.5% vs Jun 2025) with a net loss of Rs 34 Cr.

What is the 52-week high and low of Camlin Fine Sciences Ltd?

The 52-week high is Rs 211.95 and the 52-week low is Rs 92.75.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03